Product Images Oxcarbazepine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Oxcarbazepine NDC 63629-4987 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text is a graph displaying Kaplan-Meier estimates of exit rate by treatment group. The x-axis shows the time on trial from Day 2 (days) up to Day 11, with 8 a.m. markers. The y-axis represents the exit rate. There are two treatment groups displayed in the graph; Oxcarbazepine and Placebo. The log-rank test was applied, and the p-value obtained was 0.0001.*
The figure shows Kaplan-Meier estimates of exit rate in a study with two treatment groups (HIGH and LOW). The exit rate was computed over time to exit (in days) and the plot depicts the probability of exiting over time in each group. The log-rank test was performed with a p-value of 0.0001.*
This text provides a statistical analysis of exit rates using Kaplan-Meier Estimates by treatment group. The log-rank test results show a p-value of 0.0001. However, the text also includes a section with gibberish characters and is not relevant to the analysis.*
This appears to be a packaging label for a medication called Trileptal, in tablet form. The medication is manufactured by Sun Pharma Industries Ltd., and the label includes information such as dosage (300mg), expiration date (MM/YY format), and storage instructions (room temperature between 20°-25°C or 68°-77°F). The label also includes a National Drug Code (NDC) number for identifying the medication.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.